CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Editorial2020;15:1476-1478.

JOURNAL:Eurointervention. Article Link

Major infections after bypass surgery and stenting: an overlooked but fatal complication

R Harari; S Bangalore et al. Keywords: CABG vs. PCI; major infections; 5-year mortality

Full Text PDF